We are live on ! Find out more
ABEO icon

Abeona Therapeutics

104 hedge funds and large institutions have $205M invested in Abeona Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 31 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

143% more call options, than puts

Call options by funds: $8.88M | Put options by funds: $3.65M

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

19% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 31

9% more capital invested

Capital invested by funds: $188M → $205M (+$17.3M)

4% more funds holding

Funds holding: 100104 (+4)

2.45% more ownership

Funds ownership: 69.4%71.85% (+2.4%)

Holders
104
Holders Change
+4
Holders Change %
+4%
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
22
Increased
37
Reduced
31
Closed
18
Calls
$8.88M
Puts
$3.65M
Net Calls
+$5.23M
Net Calls Change
-$1.39M
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
76
PVG Asset Management
Colorado
$66.2K +$63.3K +12,570 New
PFSRSONJ
77
Police & Firemen's Retirement System of New Jersey
New Jersey
$58K
SG Americas Securities
78
SG Americas Securities
New York
$57K +$54K +10,731 New
TC
79
Truvestments Capital
Florida
$54.3K +$34.1K +6,770 +191%
BNP Paribas Financial Markets
80
BNP Paribas Financial Markets
France
$50.4K -$2.25K -448 -4%
MCM
81
MAI Capital Management
Ohio
$29.6K +$20.1K +4,000 +247%
Legal & General Group
82
Legal & General Group
United Kingdom
$24.3K -$1.06K -211 -4%
AF
83
Allworth Financial
California
$23.7K -$141 -28 -0.6%
AIP
84
Ameritas Investment Partners
Nebraska
$23.5K
Royal Bank of Canada
85
Royal Bank of Canada
Ontario, Canada
$22K +$8.89K +1,767 +69%
TRCT
86
Tower Research Capital (TRC)
New York
$19.3K -$24.7K -4,905 -57%
California State Teachers Retirement System (CalSTRS)
87
California State Teachers Retirement System (CalSTRS)
California
$14.2K -$191 -38 -1%
FFA
88
Farther Finance Advisors
California
$11.2K +$7.05K +1,401 +194%
Osaic Holdings
89
Osaic Holdings
Arizona
$10K +$4.79K +952 +100%
New York State Common Retirement Fund
90
New York State Common Retirement Fund
New York
$9.09K
SWM
91
SHP Wealth Management
Massachusetts
$8.79K +$8.4K +1,668 New
AB
92
Amalgamated Bank
New York
$7K -$604 -120 -8%
Rockefeller Capital Management
93
Rockefeller Capital Management
New York
$6.59K
Jones Financial Companies
94
Jones Financial Companies
Missouri
$5.27K
SCM
95
Sterling Capital Management
North Carolina
$2.25K +$851 +169 +66%
PA
96
Parallel Advisors
California
$2.11K
VWWMG
97
Vermillion & White Wealth Management Group
Pennsylvania
$1.95K
UBS AM
98
UBS AM
Illinois
$706 +$675 +134 New
GI
99
GAMMA Investing
California
$474 +$211 +42 +88%
SS
100
SBI Securities
Japan
$411 -$589 -117 -60%

ABEO Hedge Fund Activity: Q4 2025 in Review

104 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2025, worth a combined $205M — up 9.2% from $188M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ABEO positions and 18 closed out — a net gain of 4 holders — while 37 added to existing stakes and 31 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $10.1M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $16.1M sold.

  • 104 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2025, up from 100 in Q3 2025.
  • Funds reported $205M of Abeona Therapeutics stock for Q4 2025, up 9.2% quarter-over-quarter.
  • 22 funds opened new Abeona Therapeutics positions in Q4 2025 and 18 closed out, a net change of +4 holders.
  • The largest Abeona Therapeutics buyer in Q4 2025 was AIGH Capital Management, an estimated $10.1M added.
  • The largest Abeona Therapeutics seller in Q4 2025 was Adage Capital Partners, an estimated $16.1M sold.

Based on aggregated 13F filings for Q4 2025.